SCHEMBL15218685

SCHEMBL15218685

CC#Cc1ccc2c(c1)C(=O)N(c1cccc(O)c1)C2=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.67
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPT P10636 1/20 0.55
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.51
ESR2 Q92731 2/20 0.48
ANPEP P15144 3/20 0.46
DPP4 P27487 3/20 0.46
USP2 O75604 1/20 0.44
TNNI3 P19429 1/20 0.44
HTT P42858 1/20 0.44
TNNT2 P45379 1/20 0.44
TNNC1 P63316 1/20 0.44
TLR9 Q9NR96 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NR1H3 Q13133 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2710552 0.90 ESR1 (0.50) ESR1NPC1RAB9AMEN1KMT2A
SCHEMBL2631559 0.89 ESR1 (0.49) ESR1NPC1RAB9AMEN1KMT2A
SCHEMBL28505830 0.86 ESR1 (0.67) ESR1NPC1RAB9AMEN1KMT2A
SCHEMBL29842698 0.86 ESR1 (0.67) ESR1NPC1RAB9AMEN1KMT2A
SCHEMBL15218684 0.85 ESR1 (0.64) ESR1NPC1RAB9AMEN1KMT2A
SCHEMBL2624619 0.84 GRM5 (0.46) ESR1MEN1KMT2AALDH1A1MAPT
SCHEMBL2631558 0.83 S100B (0.58) RAB9AMEN1KMT2AALDH1A1MAPT
SCHEMBL2624624 0.83 ESR1 (0.43) ESR1NPC1RAB9AMEN1KMT2A
SCHEMBL2625351 0.81 ALDH1A1 (0.53) ESR1NPC1RAB9AMEN1KMT2A
SCHEMBL9588495 0.81 ESR1 (1.00) ESR1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140303328-A1 CROSS-LINKER NEXAM CHEMICAL AB (SE) 2014-10-09 US disclosed
US-20140303328-A1 CROSS-LINKER NEXAM CHEMICAL AB (SE) 2014-10-09 US disclosed
US-8772418-B2 Cross-linker NEXAM CHEMICAL AB (SE) 2014-07-08 US disclosed
US-8772418-B2 Cross-linker NEXAM CHEMICAL AB (SE) 2014-07-08 US disclosed
US-20130225769-A1 CROSS-LINKER NEXAM CHEMICAL AB (SE) 2013-08-29 US disclosed
US-20130225769-A1 CROSS-LINKER NEXAM CHEMICAL AB (SE) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140303328-A1 CROSS-LINKER CAPZA2, PAPSS1, CHIA ESR1 3681/4885NPC1 4650/4885RAB9A 4817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.